CRDO has staged a sharp reversal this week, surging 24% to $237.92 — a direct contradiction of the cautious setup described in our note just two days ago, when a rising put-call ratio and climbing short interest pointed toward growing defensive positioning.
The mechanics of the reversal are visible in the positioning data. Short interest dropped 4.3% on August 4 alone, pulling back to 3.75% of the free float after building steadily through the prior week. That partial unwind — still leaving SI some 10% above where it was seven days ago — looks like a forced cover rather than a clean change of view. Notably, short interest peaked near 6% of float back in late June, then collapsed by more than a third through mid-July before rebuilding. The current level remains well below that prior peak, so there is no meaningful squeeze dynamic in play. Borrow costs have roughly doubled over the past week to 0.46%, but in absolute terms that remains extremely cheap. Availability is effectively unlimited — more than 7,000% of short interest is available to borrow — so the lending market is placing no practical constraint on either side. Options positioning has actually eased slightly from last week's cautious extreme. The put-call ratio has drifted back to 0.89 from 0.92, barely above its 20-day average of 0.88, suggesting options traders are not adding fresh downside protection into the rally.
The Street had been raising targets heading into this move, which gives bulls some cover. Barclays lifted its target to $300 from $260 in late July, while Susquehanna moved to $250 from $235 just before that. Both maintained positive ratings. Earlier, BofA Securities raised its target to $340 with a Buy in late June, alongside a fresh Outperform initiation from Evercore ISI with a $325 target. The consensus price target of around $279 now sits roughly 17% above the current price — meaningful upside on paper, though several of these targets were set when the stock was trading lower. The bull case centers on CRDO's exposure to AI-driven high-speed connectivity demand, with revenue growth guided at around 80% and partnerships with hyperscale customers driving the narrative. Bears flag concentration risk: growth is disproportionately tied to AECs, optical DSPs, and line card retimers. The Dust Photonics acquisition adds a potential cash flow drag in the near term. Valuation multiples have compressed somewhat — the price-to-earnings multiple is down roughly 5.8 points over the past 30 days — but at a trailing PE near 26 and a P/B near 9.5, the stock carries a premium that leaves little room for execution stumbles.
Insider selling is worth noting alongside this week's price jump. COO Yat Tung Lam sold roughly $9.6 million worth of shares on July 31 across multiple tranches, at prices around $210-$215 — well below today's close. Founder and CTO Chi Fung Cheng also sold a smaller amount, around $1.5 million combined, on the same day. The timing is notable: these sales happened at the tail end of a pullback period, before the sharp rebound. Neither trade carries a high significance score from ORTEX, and both are consistent with programmatic selling plans, but the pattern of selling into a dip does not read as insider conviction in the upside thesis. The 90-day net insider figure is actually a modest positive at roughly $28.8 million net purchased, but that reflects activity further back in the window rather than the most recent moves. Among institutional holders, BlackRock added approximately 1.2 million shares as of June 30, and Wellington Management added over 1.3 million in the same period — both meaningful additions that predate this week's rally.
Peers moved strongly in sympathy. ALAB gained 39% on the week and FORM rose 36%, suggesting the move in CRDO is part of a broader sector rerating rather than a CRDO-specific catalyst. ENTG and RMBS also gained double digits, underlining that the tide lifted across semiconductor connectivity names simultaneously.
The next scheduled earnings print is September 1. The two most recent reports each produced negative day-one reactions — down roughly 5% and 3% respectively — though the five-day outcome diverged (one recovered, one did not). With the stock now trading back near recent highs and analysts spread between $250 and $350, the September print will either validate the hyperscale demand story or test whether this week's recovery has gotten ahead of the fundamental setup.
See the live data behind this article on ORTEX.
Open CRDO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
